Business Context and Reporting Period
This Form 8-K Current Report was filed by U.S. Bancorp on August 30, 2006. The filing details the closing of a public offering of trust preferred securities by the Company and its subsidiary, USB Capital XI, a Delaware statutory trust.
Key Financial Metrics
- Capital Raised: $765,000,000 aggregate principal amount of 6.60% Trust Preferred Securities (Capital Securities).
- Instrument Details: The offering consists of preferred beneficial interests in the Trust, fully guaranteed on a subordinated basis by U.S. Bancorp.
- Underlying Debt: Proceeds were invested in 6.60% Income Capital Obligation Notes (ICONs) due 2066.
- Underwriters: Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Morgan Stanley & Co. Incorporated.
Material Changes
The primary material event is the successful closing of the $765 million capital securities offering on August 30, 2006. This transaction increases the Company's long-term debt obligations and capital base. The filing incorporates a Fifth Supplemental Indenture dated August 30, 2006, to reflect this issuance.
Outlook, Risks, and Covenants
In connection with the closing, U.S. Bancorp entered into a Replacement Capital Covenant (RCC). Under this agreement, the Company has agreed not to redeem or repurchase the ICONs unless such actions are funded by the proceeds from the issuance of certain qualified securities. This covenant is designed to protect the interests of specific debtholders. The filing does not provide specific guidance on future earnings or operational outlook beyond the completion of this financing event.
Investor Verification Checklist
- Verify the final net proceeds received after underwriting fees and expenses.
- Review the specific terms of the Replacement Capital Covenant (Exhibit 99.1) to understand restrictions on future debt management.
- Confirm the impact of the new $765 million subordinated debt on the Company's regulatory capital ratios.
- Check the registration statement on Form S-3 (File No. 333-124535) for additional risk factors associated with the Trust Preferred Securities.